John D. Baird

2.5k total citations
89 papers, 1.3k citations indexed

About

John D. Baird is a scholar working on Molecular Biology, Small Animals and Infectious Diseases. According to data from OpenAlex, John D. Baird has authored 89 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 18 papers in Small Animals and 13 papers in Infectious Diseases. Recurrent topics in John D. Baird's work include Veterinary Equine Medical Research (8 papers), Vector-borne infectious diseases (8 papers) and Viral Infections and Vectors (6 papers). John D. Baird is often cited by papers focused on Veterinary Equine Medical Research (8 papers), Vector-borne infectious diseases (8 papers) and Viral Infections and Vectors (6 papers). John D. Baird collaborates with scholars based in Canada, United States and Australia. John D. Baird's co-authors include Scott E. Denmark, Luis G. Arroyo, Stephanie J. Valberg, Anna M. Firshman, Christopher S. Regens, Taraka Dale, Martin J. Serra, Éric Westhof, J. Scott Weese and Modest Vengušt and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

John D. Baird

85 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John D. Baird Canada 19 354 294 221 194 153 89 1.3k
M Naiki Japan 18 132 0.4× 591 2.0× 292 1.3× 74 0.4× 107 0.7× 52 1.2k
A. Corradi Italy 20 49 0.1× 250 0.9× 146 0.7× 38 0.2× 207 1.4× 77 1.2k
Jon S. Patterson United States 17 33 0.1× 302 1.0× 166 0.8× 66 0.3× 114 0.7× 47 1.1k
R. von Fellenberg Switzerland 17 19 0.1× 376 1.3× 57 0.3× 283 1.5× 25 0.2× 59 1.1k
Fernando Constantino‐Casas United Kingdom 15 43 0.1× 81 0.3× 262 1.2× 41 0.2× 30 0.2× 52 747
Kristina A. Thomsson Sweden 21 327 0.9× 1.4k 4.9× 24 0.1× 5 0.0× 207 1.4× 39 2.2k
J. Goudswaard Netherlands 15 18 0.1× 314 1.1× 114 0.5× 9 0.0× 88 0.6× 54 1.1k
S. M. Dennis United States 21 19 0.1× 343 1.2× 161 0.7× 21 0.1× 28 0.2× 79 1.5k
Willie L. Chapman United States 20 127 0.4× 249 0.8× 52 0.2× 6 0.0× 84 0.5× 63 1.3k
Thomas L. McDonald United States 19 10 0.0× 358 1.2× 223 1.0× 30 0.2× 74 0.5× 47 1.2k

Countries citing papers authored by John D. Baird

Since Specialization
Citations

This map shows the geographic impact of John D. Baird's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John D. Baird with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John D. Baird more than expected).

Fields of papers citing papers by John D. Baird

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John D. Baird. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John D. Baird. The network helps show where John D. Baird may publish in the future.

Co-authorship network of co-authors of John D. Baird

This figure shows the co-authorship network connecting the top 25 collaborators of John D. Baird. A scholar is included among the top collaborators of John D. Baird based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John D. Baird. John D. Baird is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tine, Brian A. Van, Matthew Ingham, Steven Attia, et al.. (2024). Phase Ib Study of Unesbulin (PTC596) Plus Dacarbazine for the Treatment of Locally Recurrent, Unresectable or Metastatic, Relapsed or Refractory Leiomyosarcoma. Journal of Clinical Oncology. 42(20). 2404–2414. 3 indexed citations
2.
Gao, Lan, Diksha Kaushik, Brian A. Van Tine, et al.. (2023). Pharmacokinetics of dacarbazine and unesbulin and CYP1A2‐mediated drug interactions in patients with leiomyosarcoma. Clinical and Translational Science. 17(2). 1 indexed citations
3.
Kong, Ronald, et al.. (2023). Quantitative Systems Toxicology Modeling Informed Safe Dose Selection of Emvododstat in Acute Myeloid Leukemia Patients. Clinical Pharmacology & Therapeutics. 115(3). 525–534. 5 indexed citations
4.
Branstrom, Arthur, Liangxian Cao, Bansri Furia, et al.. (2022). Emvododstat, a Potent Dihydroorotate Dehydrogenase Inhibitor, Is Effective in Preclinical Models of Acute Myeloid Leukemia. Frontiers in Oncology. 12. 832816–832816. 10 indexed citations
5.
Teymournejad, Omid, Mingqun Lin, Ramiro E. Toribio, et al.. (2020). Isolation and Molecular Analysis of a NovelNeorickettsiaSpecies That Causes Potomac Horse Fever. mBio. 11(1). 18 indexed citations
6.
Dey, Anindya, Shailendra Kumar Dhar Dwivedi, Kai Ding, et al.. (2018). Inhibition of BMI1, a Therapeutic Approach in Endometrial Cancer. Molecular Cancer Therapeutics. 17(10). 2136–2143. 14 indexed citations
7.
Cao, Liangxian, Arthur Branstrom, John D. Baird, et al.. (2017). PTC299 Is a Novel DHODH Inhibitor That Modulates VEGFA mRNA Translation and Inhibits Proliferation of a Broad Range of Leukemia Cells. Blood. 130. 1371–1371. 1 indexed citations
8.
Shapiro, Geoffrey I., Jon Infante, Todd M. Bauer, et al.. (2016). Initial first-in-human phase 1 results of PTC596, a novel small molecule that targets cancer stem cells (CSCs) by reducing BMI1 protein levels. Annals of Oncology. 27. vi122–vi122. 2 indexed citations
9.
10.
Baird, John D., Luis G. Arroyo, Modest Vengušt, et al.. (2006). Adverse extrapyramidal effects in four horse given fluphenazine decanoate. Journal of the American Veterinary Medical Association. 229(1). 104–110. 14 indexed citations
11.
Spirito, Flavia, et al.. (2002). Animal Models for Skin Blistering Conditions: Absence of Laminin 5 Causes Hereditary Junctional Mechanobullous Disease in the Belgian Horse. Journal of Investigative Dermatology. 119(3). 684–691. 60 indexed citations
12.
Fayer, Ronald, I. G. Mayhew, John D. Baird, et al.. (1990). Epidemiology of Equine Protozoal Myeloencephalitis in North America Based on Histologically Confirmed Cases. Journal of Veterinary Internal Medicine. 4(2). 54–57. 46 indexed citations
13.
Fayer, Ronald, I. G. Mayhew, John D. Baird, et al.. (1990). Epidemiology of Equine Protozoal Myeloencephalitis in North America Based on Histologically Confirmed Cases. Journal of Veterinary Internal Medicine. 4(2). 54–57. 4 indexed citations
14.
Baird, John D. & Charles D. Mackenzie. (1974). CEREBELLAR HYPOPLASIA AND DEGENERATION IN PART‐ARAB HORSES. Australian Veterinary Journal. 50(1). 25–28. 18 indexed citations
15.
Baird, John D., et al.. (1974). SPASTIC PARESIS IN FRIESIAN CALVES. Australian Veterinary Journal. 50(6). 239–245. 10 indexed citations
16.
Baird, John D., et al.. (1974). Cryptococcosis in a cat. New Zealand Veterinary Journal. 22(5). 78–81. 2 indexed citations
17.
Watson, A. D. J., et al.. (1973). HYPERTROPHIC OSTEODYSTROPHY IN DOG. Australian Veterinary Journal. 49(9). 433–439. 15 indexed citations
18.
Baird, John D.. (1973). NEONATAL MALADJUSTMENT SYNDROME IN A THOROUGHBRED FOAL. Australian Veterinary Journal. 49(11). 530–534. 7 indexed citations
19.
Baird, John D.. (1971). LACTATION TETANY (ECLAMPSIA) IN A SHETLAND PONY MARE. Australian Veterinary Journal. 47(8). 402–404. 3 indexed citations
20.
Baird, John D., et al.. (1970). PHENOTHIAZINE POISONING IN A THOROUGHBRED HORSE. Australian Veterinary Journal. 46(10). 496–499. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Naiki Breakdown of academic impact, for papers by A. Corradi Breakdown of academic impact, for papers by Jon S. Patterson Breakdown of academic impact, for papers by R. von Fellenberg Breakdown of academic impact, for papers by Fernando Constantino‐Casas Breakdown of academic impact, for papers by Kristina A. Thomsson Breakdown of academic impact, for papers by J. Goudswaard Breakdown of academic impact, for papers by S. M. Dennis Breakdown of academic impact, for papers by Willie L. Chapman Breakdown of academic impact, for papers by Thomas L. McDonald
Rankless by CCL
2026